Clinical Trial Update: GRIB Forsoeget-2004 [Phase 2]

View source ↗

Summary

Phase 2 trial GRIB Forsoeget-2004 for overweight has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight

Snippet

Sponsor: Forskningspuljen | Conditions: Overweight | Phase 2 | Status: COMPLETED